ALPHA | ALPHA IVF GROUP BERHAD [NS]
0.285 (1.79%)
T-O (am): 0.280 (08:59:00)
Last updated: 16:50
ALPHA [NS] Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
ALPHA [NS] Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
ALPHA [NS] Historical Dividends
ALPHA [NS] Financial Ratios
| EPS | 1.17 sen |
| Trailing PE (Sector Median: 26.1) | 24.3 |
| PEG | 0.85 |
| Altman Z | 4.9 |
| Beaver | 1.108 |
| Current Ratio | 2.92 |
| Debt-Equity (DE) Ratio | 0.63 |
| FCF Yield | 2.44 % |
| Revenue QoQ | 0.58 % |
| Revenue YoY | 12.2% |
| Profit QoQ | 5.0 % |
| Profit YoY | 23.63 % |
| Profit Margin (Sector Median: 8.0) | 32.86 % |
| ROE (ROIC: 88.79) | 88.79 % |
| Dividend Per Share (DPS) | 0.94 sen |
| Dividend Yield (DY) | 3.3 % |
ALPHA [NS] Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 26.1) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 8.0) | |
| ROE (ROIC: 88.82) | |
| Altman Z |
ALPHA [NS] Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.04 |
| Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 15.1 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0 |
| Expected Revenue (M) | 0 |
| Expected Growth (%) | 0 |
ALPHA [NS] Directors Share Purchases (Beta)
No transaction in the last 2 months.
ALPHA [NS] Summary
Market Cap: 1385 M.
Market Cap Class: Middlers
Number of Shares: 4860 M.
Adjusted Float: 0%.
Alpha IVF Group Berhad is a leading provider of assisted reproductive services (ARS). The company specializes in advanced fertility treatments such as in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT). Alpha IVF also offers a range of supporting medical services, including andrology, embryology, and cryopreservation, catering to individuals and couples facing fertility challenges. With state-of-the-art laboratory facilities and a team of experienced medical specialists, the group emphasizes innovative and patient-centered care. Committed to excellence in reproductive healthcare, Alpha IVF serves a diverse clientele, locally and internationally, with a focus on achieving positive patient outcomes and advancing fertility science. Alpha IVF was incorporated in 2021 and headquartered in Petaling Jaya, Selangor, Malaysia.
Sectors: Healthcare, Health Care Providers, Penny Stocks
Code: 0303
Website: http://www.alphaivfgroup.com
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
ALPHA [NS] Top Shareholdings
| Shareholder | % | Value (M) |
|---|---|---|
| Dato' Dr Lee Soon Soo | 35.11% | 486.35 |
| Ace Specialists Sdn Bhd | 9.15% | 126.78 |
| Madam Lee Soon Ai | 8.91% | 123.47 |
| Dr Ng Peng Wah | 8.33% | 115.36 |
| Dr Leong Wai Yew | 6.58% | 91.1 |
| Datuk Lee Say Tshin | 0.07% | 0.96 |
| Madam Sia Bee Keng | 0.01% | 0.19 |
| Dato Dr Tan Kee Kwong | 0.01% | 0.14 |
| Tung Fook Heng | 0.01% | 0.08 |